Utah Medical Products (UTMD) Stock Forecast, Price & News

Utah Medical Products' stock was trading at $100.53 at the beginning of the year. Since then, UTMD stock has decreased by 16.2% and is now trading at $84.28.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 24th 2023.
View our UTMD earnings forecast.

Utah Medical Products, Inc. (NASDAQ:UTMD) announced its earnings results on Tuesday, July, 25th. The medical instruments supplier reported $1.15 EPS for the quarter. The medical instruments supplier earned $12.87 million during the quarter. Utah Medical Products had a trailing twelve-month return on equity of 14.93% and a net margin of 33.22%.

Utah Medical Products announced a quarterly dividend on Thursday, September 14th. Investors of record on Friday, September 15th will be paid a dividend of $0.295 per share on Tuesday, October 3rd. This represents a $1.18 annualized dividend and a dividend yield of 1.40%. The ex-dividend date of this dividend is Thursday, September 14th.
Read our dividend analysis for UTMD.

Utah Medical Products (NASDAQ:UTMD) pays an annual dividend of $1.18 per share and currently has a dividend yield of 1.38%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 24.89%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for UTMD.

8 employees have rated Utah Medical Products Chief Executive Officer Kevin L. Cornwell on Glassdoor.com. Kevin L. Cornwell has an approval rating of 43% among the company's employees. This puts Kevin L. Cornwell in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), Walt Disney (DIS), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR) and

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

Utah Medical Products' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (5.60%), BlackRock Inc. (5.42%), Dimensional Fund Advisors LP (4.27%), Rice Hall James & Associates LLC (3.11%), Ranger Investment Management L.P. (2.17%) and State Street Corp (1.95%). Insiders that own company stock include Barbara A Payne, Barbara A Payne, Ernst G Hoyer and Paul O Richins.
View institutional ownership trends.

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of UTMD stock can currently be purchased for approximately $84.28.

Utah Medical Products (NASDAQ:UTMD) has a market capitalization of $305.94 million and generates $52.28 million in revenue each year. The medical instruments supplier earns $16.47 million in net income (profit) each year or $4.74 on an earnings per share basis.

The company employs 186 workers across the globe.

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The official website for the company is www.utahmed.com. The medical instruments supplier can be reached via phone at (801) 566-1200 or via fax at 801-566-7305.